Visit Lucid news for the latest in psychedelics
Psychedelic U offers a starting point for those new to psychedelics and for experienced psychonauts alike. We publish clear, fact checked articles reviewed by top experts, as well as Lucid News editors. The articles include links to recommended resources for more detailed, vetted information. This site is now in public beta. It’s a living document, responsive to your feedback. Please send suggestions and corrections. New content modules are coming soon. Sign up for our newsletter to receive announcements and opportunities to be a part of this effort to make reliable information about psychedelics widely available.
More people than ever are curious about psychedelics, the substances – plants, fungi and compounds – that create expanded states of consciousness. New research shows these substances could be promising medicines, particularly in conjunction with therapy. A central element of Indigenous spiritual practices since ancient times, psychoactive substances are now being embraced by other cultures to support personal growth, creativity and a deeper connection to the divine.
Ketamine, unlike the classic psychedelic substances, is a legal dissociative anesthetic that is used…
There are myriad ways to experience psychedelics, from clinical therapy to ceremony to recreationally…
Research suggests psilocybin may have potential as a treatment for OCD. Psilocybin interacts with…

Resilient Pharmaceuticals (formerly Lykos Therapeutics and MAPS PBC), reportedly resubmitted their once-rejected New Drug Application (NDA) for MDMA-assisted therapy for PTSD to the FDA, triggering a fresh review cycle under the agency’s newly finalized psychedelic clinical trial guidance.

The FDA has finalized guidance on clinical investigations into psychedelic-assisted therapies and contract research organization ICON will bring Anthropic’s Claude AI tool into clinical trials involving drug development.

In this week’s psychedelic policy briefing, investigative journalist Jack Gorsline unpacks a wave of state and federal initiatives aimed at expanding alternative therapies for veterans and those battling addiction.